---
title: "ADA senior scientific officer departs as internal review of June incident continues"
id: "stat-news-0-stat-another-diabetes-association-leader-is-out-while-review-continues"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-0-stat-another-diabetes-association-leader-is-out-while-review-continues"
content_type: "clinical_feed_article"
specialty: "Endocrinology"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/10/21/american-diabetes-association-leadership-change-controversy/?utm_campaign=rss"
published_at: "2026-10-21T19:59:48.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# ADA senior scientific officer departs as internal review of June incident continues
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-0-stat-another-diabetes-association-leader-is-out-while-review-continues
- **Specialty:** [Endocrinology](https://medichelpline.com/clinical-feed/endocrinology.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/10/21/american-diabetes-association-leadership-change-controversy/?utm_campaign=rss)
- **Published At:** 2026-10-21T19:59:48.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The American Diabetes Association announced that **Rita Kalyani**, its chief scientific and medical officer, "is no longer in her role, effective immediately," according to the ADA notice cited in the source. The organization thanked her for years of service. - The departure occurred just over six weeks after the ADA said a review of an incident at its June New Orleans meeting would need more time; the review remains ongoing and unresolved. - The June incident involved five members being escorted out by armed security for distributing an April editorial published in the ADA’s journal **Diabetes Care** that criticized cuts to federal research funding. - The source reported no explanation for Dr. Kalyani’s departure; the ADA’s public notice offered no further details beyond a statement of thanks from CEO Charles Henderson. - Investigative and reporting details beyond the ADA notice were not provided in the source; STAT indicated the full story is behind its STAT+ subscriber paywall. - The cohort of events includes the organization’s public acknowledgment of an ongoing review, an earlier STAT report on the June expulsions, and the subsequent leadership change; connections between those elements were reported but not fully explained in the source. - The source did not report specific internal review findings, timelines for completion, whether an external investigator is involved, or any personnel actions beyond Dr. Kalyani’s departure. - The available reporting places the personnel change in a broader chronology: June expulsions, ADA announcement of extended review, then the October departure notice; the sequence was reported without attribution of cause. - Data or documentation—such as meeting minutes, investigative reports, or direct quotations from the five members escorted out—were not included in the source article. - Key unanswered questions remain in the public record according to the source: why Dr. Kalyani left now, who will assume her duties, what the review has uncovered to date, and whether there will be further personnel or governance actions.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/10/21/american-diabetes-association-leadership-change-controversy/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/10/21/american-diabetes-association-leadership-change-controversy/?utm_campaign=rss) [ethics](https://www.statnews.com/topic/ethics/) [diagnostics](https://www.statnews.com/topic/diagnostics/) [Medical devices](https://www.statnews.com/topic/medical-devices/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [Midterms 2026](https://www.statnews.com/midterms-2026-health-care-policy-issues/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)[Health](https://www.statnews.com/category/health/) # Another diabetes association leader is out while review continues ## No explanation offered for departure before report on June expulsions is completed * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/10/21/american-diabetes-association-leadership-change-controversy/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2026/10/AdobeStock_2054369097_Editorial_Use_Only-645x645.jpeg) Adobe ![](https://www.statnews.com/wp-content/uploads/2021/02/liz-c-avatar-small2-80x80.png) By [Elizabeth Cooney](https://www.statnews.com/staff/elizabeth-cooney/) Oct. 21, 2026 Cardiovascular Disease Reporter ![](https://www.statnews.com/wp-content/uploads/2021/02/liz-c-avatar-small2-80x80.png) [Elizabeth Cooney](https://www.statnews.com/staff/elizabeth-cooney/) 1. [](https://x.com/cooney_liz "X") elizabeth.cooney@statnews.com Liz covers cardiovascular and metabolic disease, asking [why we’re not doing better](https://www.statnews.com/2024/10/15/cardiovascular-disease-rising-experts-on-causes/) or even [losing ground](https://www.statnews.com/2024/04/24/heart-failure-deaths-decline-undone/) against the world’s leading killer. Send tips on Signal at LizC.22. Just over six weeks after the American Diabetes Association said its [review](https://diabetes.org/newsroom/press-releases/ada-board-receive-additional-information-audit-and-governance-committee) of an [incident](https://www.statnews.com/2026/09/01/ada-members-review-june-expulsion-denies-censoring-opinions-calling-new-orleans-police/) at its New Orleans meeting in June would need more time, one of its top leaders is out. Rita Kalyani, chief scientific and medical officer, “is no longer in her role, effective immediately,” [Tuesday’s notice](https://diabetes.org/newsroom/press-releases/american-diabetes-association-announces-transition-chief-scientific-and-0) from the ADA said. “We thank Dr. Kalyani for her dedication to the ADA’s mission over the years,” CEO Charles Henderson said. Advertisement The organization has been in some turmoil since June 5, when five members were escorted out by armed security officers for handing out an April [editorial](https://diabetesjournals.org/care/article/49/6/901/164764/Misguided-Brushes-of-a-Pen-Continue-to-Dismantle), published in the ADA’s journal Diabetes Care, that voiced alarm over cuts to federal research funding. STAT+ Exclusive Story Already have an account? [Log in](https://www.statnews.com/login/) ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-breaker-bg.png) [ ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo-white.svg) ](https://www.statnews.com/stat-plus/) ## This article is exclusive to STAT+ subscribers ### Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? [Log in](https://www.statnews.com/login/) Individual plans Group plans Monthly $39 Totals $468 per year [$39/month](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) Totals $468 per year Starter $30 for 3 months, then $399/year [$30 for 3 months](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) Then $399/year Annual $399 Save 15% [$399/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) Save 15% 11+ Users Custom Savings start at 25%! [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) Savings start at 25%! 2-10 Users $300 Annually per user [$300/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) $300 Annually per user [View All Plans](https://www.statnews.com/stat-plus/) [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [chronic disease](https://www.statnews.com/topic/chronic-disease/), [diabetes](https://www.statnews.com/topic/diabetes/), [NIH](https://www.statnews.com/topic/nih/), [research](https://www.statnews.com/topic/research/), [STAT+](https://www.statnews.com/topic/stat-plus/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2021/02/liz-c-avatar-small2-80x80.png) [Elizabeth Cooney](https://www.statnews.com/staff/elizabeth-cooney/) 1. [](https://x.com/cooney_liz "X") 2. [](https://bsky.app/profile/elizabethcooney.bsky.social "Bluesky") 3. Cardiovascular Disease Reporter 1. [](https://x.com/cooney_liz "X") 2. [](https://bsky.app/profile/elizabethcooney.bsky.social "Bluesky") 3. Liz covers cardiovascular and metabolic disease, asking [why we’re not doing better](https://www.statnews.com/2024/10/15/cardiovascular-disease-rising-experts-on-causes/) or even [losing ground](https://www.statnews.com/2024/04/24/heart-failure-deaths-decline-undone/) against the world’s leading killer. Send tips on Signal at LizC.22. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/Morning-Rounds-Logo-Black-640x295.png) ### Newsletter Understand how science, health policy, and medicine shape the world every day Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/10/https___cdn.sanity.io_images_xq1bjtf4_production_964fa47326a827f12bf336e880b2fdc4665711e6-5973x4480-1-80x80.jpg) [I was a Theranos whistleblower. In ‘You Can See Everything,’ Elizabeth Holmes is still lying](https://www.statnews.com/2026/10/19/elizabeth-holmes-theranos-whistleblower-tyler-shultz-insider-review/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/10/GettyImages-2263715743-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Mark Cuban wants to crack open the market for rare disease treatments](https://www.statnews.com/2026/10/21/mark-cuban-cost-plus-drugs-rare-disease-medicines/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/10/GettyImages-491436280-80x80.jpg) [Why I wish you didn’t want to see Nathan Fielder’s Elizabeth Holmes documentary](https://www.statnews.com/2026/10/20/elizabeth-holmes-superpower-authenticity-vs-truth-matt-herper-take/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/10/GettyImages-2259640923-80x80.jpg) [A counterintuitive way to build trust in measles vaccines and public health](https://www.statnews.com/2026/10/21/measles-vaccination-uptake-experts-suggest-messaging-change/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/10/L4A2797-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A German biotech has big ambitions in cancer. Now it needs to get a medicine approved](https://www.statnews.com/2026/10/21/immatics-cancer-cell-therapy-targets-prame-protein/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/TevaPF_Wordpress_CalendarImage-80x80.jpg) The Next Era of Biosimilars: Rewriting the Playbook Virtual Oct 19 ](https://www.statnews.com/event/next-era-of-biosimilars-rewriting-the-playbook/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/ESMORecap_Wordpress_CalendarImage-80x80.jpg) ESMO 2026: The STAT Recap Virtual Oct 29 ](https://www.statnews.com/event/esmo-2026-the-stat-recap/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/2026ASH_Wordpress_CalendarImage-80x80.jpg) STAT@ASH: Medicine’s Bleeding Edge New Orleans, LA Dec 13 ](https://www.statnews.com/event/stat-at-ash-meeting-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2025/07/GettyImages-2208174977-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [In DOGE’s aftermath, federal health workers bristle at new performance reviews](https://www.statnews.com/2026/10/16/federal-performance-reviews-health-agency-employees-wary-after-doge/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/10/unnamed-1-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [On Wall Street, there’s trouble stirring for biotech](https://www.statnews.com/2026/10/15/wall-street-biotech-trouble-stirring/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/10/4LK3WINEDMMIR2JEHVX56ICPOY-80x80.avif) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Jury rules in favor of ousted Cambridge scientist David Sabatini, with $6 million in damages to be awarded](https://www.statnews.com/2026/10/16/david-sabatini-wins-sexual-misconduct-lawsuit-metoo/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/07/AdobeStock_1383731-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Trump administration delays new rule that could restrict imported medicines from Canada and overseas](https://www.statnews.com/pharmalot/2026/10/14/trump-administration-delays-new-rule-that-could-restrict-imported-meds-from-canad-and-overseas/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/09/STAT26_NoSurprisesAct_Fin-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [How the No Surprises Act’s nonprofit arbitrators are operating like ‘mini gods’ and getting rich doing it](https://www.statnews.com/2026/10/19/no-surprises-act-billing-arbitration-profits-stat-investigation/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) AI Prognosis AI Prognosis October 21, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: What’s the deal with Isomorphic Labs? ](https://www.statnews.com/2026/10/21/whats-the-deal-with-isomorphic-labs-ai-prognosis/) By [Brittany Trang](https://www.statnews.com/staff/brittany-trang/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout The Readout October 21, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: GSK picks up hep B drug approval ](https://www.statnews.com/2026/10/21/biotech-news-gsk-picks-up-hep-b-drug-approval/) By [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) and [Andrew Joseph](https://www.statnews.com/staff/andrew-joseph/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Pharmalot Pharmalot October 21, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Pharmalittle: We’re reading about Mark Cuban eyeing rare disease drugs, a ketamine gold rush, and more ](https://www.statnews.com/pharmalot/2026/10/21/mark-cuban-eyes-rare-disease-drugs-ketamine-gold-rush/) By [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech October 21, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Roivant says closely watched immune drug succeeded in new eye disease ](https://www.statnews.com/2026/10/21/roivant-immune-drug-lisraya-noninfectious-uveitis-trial-results/) By [Jason Mast](https://www.statnews.com/staff/jason-mast/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Morning Rounds Morning Rounds October 21, 2026 ### [ Nigeria identifies travel-related Ebola case ](https://www.statnews.com/2026/10/21/health-news-nigeria-travel-related-ebola-case-outbreak/) By [Theresa Gaffney](https://www.statnews.com/staff/theresa-gaffney/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: How the No Surprises Act’s nonprofit arbitrators are operating like 'mini gods' and getting rich doing it ](https://www.statnews.com/2026/10/19/no-surprises-act-billing-arbitration-profits-stat-investigation/) By [Tara Bannow](https://www.statnews.com/staff/tara-ba
## Related Clinical Research

- [Semaglutide plus menopause hormone therapy linked to greater weight loss in midlife women](https://medichelpline.com/clinical-feed/medical-news-today-0-ozempic-plus-hormone-therapy-may-help-boost-weight-loss-at-menopause.md)
- [High-Fiber Diet Outperforms Metformin in Blood Sugar Control and Weight Loss](https://medichelpline.com/clinical-feed/medical-news-today-0-high-fiber-diet-vs-metformin-which-is-better-for-blood-sugar-control-weight-loss.md)
- [AbbVie’s lutikizumab meets Phase 3 endpoint in hidradenitis suppurativa but falls short of market](https://medichelpline.com/clinical-feed/stat-news-1-stat-abbvie-skin-disorder-drug-succeeds-in-late-stage-trial-but-results-miss.md)
- [Nutrition experts urge White House to publish proposed ultra-processed foods definition](https://medichelpline.com/clinical-feed/stat-news-2-stat-nutrition-experts-press-white-house-to-release-ultra-processed-food.md)

## Navigation
- [← Back to Endocrinology Feed](https://medichelpline.com/clinical-feed/endocrinology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.